Literature DB >> 24624352

A rare case of acute leukemic presentation of blastic plasmacytoid dendritic cell neoplasm without cutaneous lesions.

Shinae Yu1, Min-Jung Kwon1, Kyungeun Kim2, Dong-Hoe Koo3, Hee-Yeon Woo1, Hyosoon Park1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24624352      PMCID： PMC3948829          DOI： 10.3343/alm.2014.34.2.148

Source DB:  PubMed          Journal:  Ann Lab Med        ISSN： 2234-3806            Impact factor:   3.464


× No keyword cloud information.
  12 in total

1.  Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Janneke C Ham; Jeroen J W M Janssen; James E Boers; Philip M Kluin; Leo F Verdonck
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

Review 2.  WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.

Authors:  Günter Burg; Werner Kempf; Antonio Cozzio; Josef Feit; Rein Willemze; Elaine S Jaffe; Reinhard Dummer; Emilio Berti; Lorenzo Cerroni; Sergio Chimenti; José L Diaz-Perez; Florent Grange; Nancy L Harris; Dmitry V Kazakov; Helmut Kerl; Michael Kurrer; Robert Knobler; Chris J L M Meijer; Nicola Pimpinelli; Elisabeth Ralfkiaer; Robin Russell-Jones; Christian Sander; Marco Santucci; Wolfram Sterry; Steven H Swerdlow; Maarten H Vermeer; Janine Wechsler; Sean Whittaker
Journal:  J Cutan Pathol       Date:  2005-11       Impact factor: 1.587

3.  The first case of blastic plasmacytoid dendritic cell neoplasm with MLL-ENL rearrangement.

Authors:  Takashi Toya; Nahoko Nishimoto; Junji Koya; Masahiro Nakagawa; Fumihiko Nakamura; Koji Kandabashi; Go Yamamoto; Yasuhito Nannya; Motoshi Ichikawa; Mineo Kurokawa
Journal:  Leuk Res       Date:  2011-08-09       Impact factor: 3.156

4.  Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

Authors:  Marco Lucioni; Francesca Novara; Giacomo Fiandrino; Roberta Riboni; Daniele Fanoni; Mariarosa Arra; Luigia Venegoni; Marta Nicola; Elena Dallera; Luca Arcaini; Francesco Onida; Pamela Vezzoli; Erica Travaglino; Emanuela Boveri; Orsetta Zuffardi; Marco Paulli; Emilio Berti
Journal:  Blood       Date:  2011-09-07       Impact factor: 22.113

5.  Clinical and biologic features of CD4(+)CD56(+) malignancies.

Authors:  Jean Feuillard; Marie-Christine Jacob; Françoise Valensi; Marc Maynadié; Rémy Gressin; Laurence Chaperot; Christine Arnoulet; Françoise Brignole-Baudouin; Bernard Drénou; Eliane Duchayne; Annie Falkenrodt; Richard Garand; Emanuelle Homolle; Bernard Husson; Emilienne Kuhlein; Geneviève Le Calvez; Danielle Sainty; Marie-France Sotto; Franck Trimoreau; Marie-Christine Béné
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

Authors:  Dominique Leroux; Francine Mugneret; Mary Callanan; Isabelle Radford-Weiss; Nicole Dastugue; Jean Feuillard; Franseza Le Mée; Ghislaine Plessis; Pascaline Talmant; Nathalie Gachard; Françoise Uettwiller; Marie-Pierre Pages; Marie-Joëlle Mozziconacci; Virginie Eclache; Catherine Sibille; Hervé Avet-Loiseau; Marina Lafage-Pochitaloff
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

Review 7.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Authors:  Michael J Rauh; Fazlur Rahman; David Good; Jeffrey Silverman; Michael K Brennan; Nikolay Dimov; Jane Liesveld; Daniel H Ryan; W Richard Burack; John M Bennett
Journal:  Leuk Res       Date:  2011-09-03       Impact factor: 3.156

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.

Authors:  Thomas Wiesner; Anna C Obenauf; Carlo Cota; Isabella Fried; Michael R Speicher; Lorenzo Cerroni
Journal:  J Invest Dermatol       Date:  2009-11-19       Impact factor: 8.551

10.  CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.

Authors:  M W Bekkenk; P M Jansen; C J L M Meijer; R Willemze
Journal:  Ann Oncol       Date:  2004-07       Impact factor: 32.976
View more
  1 in total

1.  Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.

Authors:  Zhenya Tang; Guilin Tang; Sa A Wang; Xinyan Lu; Ken H Young; Carlos E Bueso-Ramos; Yesid Alvarado; L Jeffrey Medeiros; Joseph D Khoury
Journal:  Mol Cytogenet       Date:  2016-02-27       Impact factor: 2.009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.